Literature DB >> 27730796

Acenocoumarol: A Review of Anticoagulant Efficacy and Safety.

Abhijit Trailokya1, J S Hiremath2, Jps Sawhney3, Y K Mishra4, Vivek Kanhere5, R Srinivasa6, Mangesh Tiwaskar7.   

Abstract

Anticoagulant treatment is required for the treatment and prevention of thromboembolic disorders. Vitamin K antagonists are commonly used oral anticoagulants worldwide. Acenocoumarol is mono-coumarin derivative with racemic mixture of R (+) and S (-) enantiomers. Efficacy and safety of acenocoumarol has been evaluated in atrial fibrillation, cardiac valve replacement, after myocardial infarction, treatment of deep vein thrombosis, after major surgeries and after critical illness requiring prolonged hospitalization. Acenocoumarol is effective and safe in all age groups. It offers an advantage over warfarin in terms of better stability of anti-coagulant effect. Due to its economic advantage acenocoumarol may be suitable oral anticoagulant for long term use in countries like India. © Journal of the Association of Physicians of India 2011.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27730796

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  7 in total

1.  Acenocoumarol as an alternative anticoagulant in a patient with warfarin-related nephropathy.

Authors:  Sapan Kumar Behera; Alphienes Stanley Xavier; Sandhiya Selvarajan; Hemachandren Munuswamy; Satish Haridasan; Bheemanathi Hanuman Srinivas
Journal:  Br J Clin Pharmacol       Date:  2018-02-28       Impact factor: 4.335

2.  Evaluation of oral anticoagulants with vitamin K epoxide reductase in its native milieu.

Authors:  Xuejie Chen; Da-Yun Jin; Darrel W Stafford; Jian-Ke Tie
Journal:  Blood       Date:  2018-08-08       Impact factor: 22.113

Review 3.  Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies.

Authors:  Raminderjit Kaur; Manpreet Kaur; Jatinder Singh
Journal:  Cardiovasc Diabetol       Date:  2018-08-31       Impact factor: 9.951

Review 4.  Multidirectional Efficacy of Biologically Active Nitro Compounds Included in Medicines.

Authors:  Dorota Olender; Justyna Żwawiak; Lucjusz Zaprutko
Journal:  Pharmaceuticals (Basel)       Date:  2018-05-29

Review 5.  Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine.

Authors:  Cristina Lucía Dávila-Fajardo; Xando Díaz-Villamarín; Alba Antúnez-Rodríguez; Ana Estefanía Fernández-Gómez; Paloma García-Navas; Luis Javier Martínez-González; José Augusto Dávila-Fajardo; José Cabeza Barrera
Journal:  Genes (Basel)       Date:  2019-04-01       Impact factor: 4.096

6.  Acenocoumarol's pharmacokinetic: linear or not?

Authors:  Parveen Kumar; Puneet Kapoor; Chhikara Meenu
Journal:  EXCLI J       Date:  2019-08-27       Impact factor: 4.068

7.  (E)-N'-(1-(7-Hydroxy-2-Oxo-2H-Chromen-3-Yl) Ethylidene) Benzohydrazide, a Novel Synthesized Coumarin, Ameliorates Isoproterenol-Induced Myocardial Infarction in Rats through Attenuating Oxidative Stress, Inflammation, and Apoptosis.

Authors:  Anouar Feriani; Emna Khdhiri; Meriam Tir; Afoua Elmufti; Nizar Tlili; Raouf Hajji; Houcine Ammar; Noureddine Allouche; Souhir Abid; Lakhdar Ghazouani; Kais Mnafgui
Journal:  Oxid Med Cell Longev       Date:  2020-03-06       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.